Nature Cancer: stroke remodels brain cells in ways that can fuel glioma growth
A peer-reviewed study published 25 September 2026 in Nature Cancer from Texas Children’s Duncan NRI and Baylor College of Medicine reports that stroke promotes glioma infiltration and reduces survival in human and mouse models via tumor-associated astrocytes and immune cells — preclinical findings, not a treatment guide.
On 25 September 2026 Nature Cancer published research led by Dr. Hyun Kyoung Lee and colleagues at Texas Children’s Duncan Neurological Research Institute and Baylor College of Medicine showing that stroke can remodel the tumor microenvironment and promote glioma progression. The work combines human and mouse glioma models with single-cell and spatial analyses.
What the study found
Epidemiological work has linked prior stroke or traumatic brain injury to higher brain-tumor risk (authors cite roughly three- to seven-fold depending on age and sex). Mechanistically, the new paper reports that stroke promoted tumor infiltration into injured regions, reduced overall survival in models, and produced a distinct population of tumor-associated astrocytes (TAAs) with reduced calcium activity at the invasive front, alongside enrichment of tumor-associated microglia and macrophages (TAMs). Restoring TAA calcium signaling or depleting TAMs suppressed stroke-driven progression in the experiments; the authors also implicate SLC4A4 in TAA calcium regulation and CCL2-mediated TAM recruitment.
Study type and limits
This is peer-reviewed laboratory and model research, not a randomised trial of a therapy in patients. Findings do not mean every stroke survivor will develop glioma, nor do they establish a clinical screening protocol. The authors frame astrocytes and TAMs as potential future therapeutic targets. This article is not personal medical advice; people with neurological concerns should speak with their doctors.
Also available in: Саха тылаРусскийEspañol中文Portuguêsالعربية